OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery
Yingqi Lin, Ke-Ke Feng, Jie-Ying Lu, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 727-749
Closed Access | Times Cited: 16
Yingqi Lin, Ke-Ke Feng, Jie-Ying Lu, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 727-749
Closed Access | Times Cited: 16
Showing 16 citing articles:
Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review
Zhen Chen, Min Xiong, Jiaqi Tian, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 37
Zhen Chen, Min Xiong, Jiaqi Tian, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 37
Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy
Wenzhe Zhao, Kaixuan Li, Liangbo Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7715-7715
Open Access | Times Cited: 15
Wenzhe Zhao, Kaixuan Li, Liangbo Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7715-7715
Open Access | Times Cited: 15
Tumor MicroenvironmentâResponsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma
Lei He, Zhaozhao Li, Danjie Su, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 8
Lei He, Zhaozhao Li, Danjie Su, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 8
Core-shell vector-mediated co-delivery of CRISPR/Cas9 system and hydrophobic drugs against triple-negative breast cancer stem cells
Tong Wang, Tianyi Chen, Dazhao Li, et al.
Journal of Controlled Release (2025) Vol. 378, pp. 1080-1091
Closed Access
Tong Wang, Tianyi Chen, Dazhao Li, et al.
Journal of Controlled Release (2025) Vol. 378, pp. 1080-1091
Closed Access
Breaking barriers in targeted Therapy: Advancing exosome Isolation, Engineering, and imaging
Anastasiya Kostyusheva, Eugenia Romano, Neng Yan, et al.
Advanced Drug Delivery Reviews (2025) Vol. 218, pp. 115522-115522
Closed Access
Anastasiya Kostyusheva, Eugenia Romano, Neng Yan, et al.
Advanced Drug Delivery Reviews (2025) Vol. 218, pp. 115522-115522
Closed Access
A Semiconducting Polymer NanoCRISPR for Near-Infrared Photoactivatable Gene Editing and Cancer Gene Therapy
Yue Liu, Fei Li, Yan Lyu, et al.
Nano Letters (2025)
Closed Access
Yue Liu, Fei Li, Yan Lyu, et al.
Nano Letters (2025)
Closed Access
In Situ Gene Engineering Approach to Overcome Tumor Resistance and Enhance T Cell-Mediated Cancer Immunotherapy
Di Zhang, Wenjuan Wang, Mingtan Tang, et al.
Nano Letters (2025)
Closed Access
Di Zhang, Wenjuan Wang, Mingtan Tang, et al.
Nano Letters (2025)
Closed Access
Biomedical Applications of Hybrid Nanomaterials
Bancha Yingngam, Benjabhorn Sethabouppha, Krit Yingngam, et al.
Advances in chemical and materials engineering book series (2024), pp. 170-225
Closed Access | Times Cited: 3
Bancha Yingngam, Benjabhorn Sethabouppha, Krit Yingngam, et al.
Advances in chemical and materials engineering book series (2024), pp. 170-225
Closed Access | Times Cited: 3
Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases
Lanjie Lei, Wenjie Pan, Xin Shou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Lanjie Lei, Wenjie Pan, Xin Shou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Remotely Sequential Activation of Biofunctional MXenes for Spatiotemporally Controlled Photothermal Cancer Therapy Integrated with Multimodal Imaging
Jing Jia, Xiaobo Zhang, Yiran Li, et al.
Small (2024)
Closed Access | Times Cited: 3
Jing Jia, Xiaobo Zhang, Yiran Li, et al.
Small (2024)
Closed Access | Times Cited: 3
Current application and future perspective of CRISPR/cas9 gene editing system mediated immune checkpoint for liver cancer treatment
Ling-Wu Tong, Yongshan Hu, Shi-Jing Yu, et al.
Nanotechnology (2024) Vol. 35, Iss. 40, pp. 402002-402002
Closed Access | Times Cited: 1
Ling-Wu Tong, Yongshan Hu, Shi-Jing Yu, et al.
Nanotechnology (2024) Vol. 35, Iss. 40, pp. 402002-402002
Closed Access | Times Cited: 1
Near-infrared light responsive upconversion-DNA nanocapsules for remote-controlled CRISPR-Cas9 genome editing
Yuqing Liu, Shiling Zhang, Kai Jiang, et al.
Chinese Chemical Letters (2024), pp. 110282-110282
Closed Access | Times Cited: 1
Yuqing Liu, Shiling Zhang, Kai Jiang, et al.
Chinese Chemical Letters (2024), pp. 110282-110282
Closed Access | Times Cited: 1
Synthesis, characterization, and cellular investigation of three smart polymeric nanoparticles as efficient plasmid CRISPR (pCRISPR) delivery vehicles
Roya Khodaei, Mehrdad Bayandori, Leila Mohammad Gholinia Sarpoli, et al.
Advances in Natural Sciences Nanoscience and Nanotechnology (2024) Vol. 15, Iss. 4, pp. 045003-045003
Closed Access | Times Cited: 1
Roya Khodaei, Mehrdad Bayandori, Leila Mohammad Gholinia Sarpoli, et al.
Advances in Natural Sciences Nanoscience and Nanotechnology (2024) Vol. 15, Iss. 4, pp. 045003-045003
Closed Access | Times Cited: 1
Engineered exosomes in service of tumor immunotherapy: From optimizing tumorâderived exosomes to delivering CRISPR /Cas9 system
Mingyang Jiang, Ke Zhang, Jinfeng Meng, et al.
International Journal of Cancer (2024) Vol. 156, Iss. 5, pp. 898-913
Closed Access | Times Cited: 1
Mingyang Jiang, Ke Zhang, Jinfeng Meng, et al.
International Journal of Cancer (2024) Vol. 156, Iss. 5, pp. 898-913
Closed Access | Times Cited: 1
Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment
Meng Lin, Xueyan Wang
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 62-62
Open Access | Times Cited: 2
Meng Lin, Xueyan Wang
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 62-62
Open Access | Times Cited: 2
Peptide dendrimers transfecting CRISPR/Cas9 plasmid DNA: optimization and mechanism
Susanna Zamolo, Elena Zakharova, Lise Boursinhac, et al.
RSC Chemical Biology (2024) Vol. 5, Iss. 9, pp. 891-900
Open Access
Susanna Zamolo, Elena Zakharova, Lise Boursinhac, et al.
RSC Chemical Biology (2024) Vol. 5, Iss. 9, pp. 891-900
Open Access
